Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06896474 · ClinicalTrials.gov registry record · NA
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
A NA study of Breast Cancer, sponsored by Beth Israel Deaconess Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 402
- Enrollment target
- 11
- Study locations
NCT06896474: Recruiting NA study of Breast Cancer, sponsored by Beth Israel Deaconess Medical Center.
NCT06896474 is a NA study of Breast Cancer that is actively recruiting participants, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 402 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (86% lower). The trial reports 11 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06896474, a NA study of Breast Cancer, is actively recruiting participants, sponsored by Beth Israel Deaconess Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 402 participants
- Enrollment target
- 11
- Study locations
Study Summary
Investigators aim to conduct a type 1 hybrid effectiveness-implementation surgeon-level cluster randomized clinical trial (RCT) of a multi-level intervention, a shared decision making training for surgeons plus patient decision aid vs. usual care (UC), at 7 large health systems across the U.S. to learn the intervention's effectiveness. Decision aids will be mailed and sent via patient portal and/or via email (when portal/email addresses are available) to patients before their first surgical encounter. The central hypothesis is that the novel intervention will be a key resource to support shared decision making leading to higher quality treatment decisions and as result improved care and outcomes.
Primary Outcome
Research staff will review the medical records for all participants with eligible tumor and study characteristics seen by a participating surgeon during the trial to learn whether aggressive treatments were received (mastectomy, radiation treatment, sentinel lymph node biopsy \[SLNB\] or axillary dissections and/or systemic therapy) within 6 months of each participant's first surgical consultation.
Conditions Studied
Interventions
- BEHAVIORAL Shared Decision-Making Training and Decision Aid
Study Locations (11)
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
- Brigham and Women's Hospital - Boston
- Dana Farber Cancer Institute - Boston
- Lahey Hospital and Medical Center - Burlington
- Beth Israel Deaconess Hospital - Needham
- Dana-Farber/Brigham and Women's Cancer Center at South Shore Hospital - Weymouth
California
- Beckman Research Institute of the City of Hope - Los Angeles
New Jersey
- Rutgers State University of New Jersey Medical School - Newark
New Mexico
- University of New Mexico - Albuquerque
New York
- University of Rochester - Rochester
North Carolina
- Duke University - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 402 participants |
| Start Date | 2026-02-04 |
| Est. Completion | 2033-09-30 |
| Phase | NA |
What NCT06896474 shows while recruiting
NCT06896474 is an interventional study that assigns participants to a tested intervention. The registered 402 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Shared Decision-Making Training and Decision Aid is the first listed.
NCT06896474 lists 11 locations in 6 states (Massachusetts, California, New Jersey).
Frequently Asked Questions
What is clinical trial NCT06896474 about?
NCT06896474 is a clinical study titled "SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers". Investigators aim to conduct a type 1 hybrid effectiveness-implementation surgeon-level cluster randomized clinical trial (RCT) of a multi-level intervention, a shared decision making training for surgeons plus patient decision aid vs. usual care (UC), at 7 large health systems across the U.S. to le...
What is the current status of trial NCT06896474?
This trial is currently recruiting. It is a NA study. The enrollment target is 402 participants. The study started on 2026-02-04. Estimated completion is 2033-09-30.
What conditions does trial NCT06896474 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT06896474?
The interventions under investigation include: Shared Decision-Making Training and Decision Aid (BEHAVIORAL).
Who is sponsoring clinical trial NCT06896474?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06896474 being conducted?
This trial has 11 study locations across California, Massachusetts, New Jersey, New Mexico, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06896474's enrollment target sits among peer trials
402 230th of 1224 higher than 994 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04464226 · 402 participants · Phase 3
Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer
- NCT05183763 · 402 participants · NA
Medication Adherence Program
- NCT05647122 · 403 participants · Phase 1
First in Human Study of AZD9592 in Solid Tumors
- NCT05674799 · 403 participants · NA
NDPP-NextGen: A Clinical Trial to Reduce Intergenerational Obesity and Diabetes Risks
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI